Profile
Full Name
VYNE Therapeutics Inc.Ticker Symbol
VYNEExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
January 25, 2018Indexes
Not includedWebsite
http://vynetherapeutics.comEmployees
13Key Details
Price
$1.55(+5.07%)
Market cap
$23.65M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$501.00K(+18.16% YoY)
Annual EPS
-$0.93(+66.55% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
VYNE Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 6, 25 HC Wainwright & Co.
BuyFeb 19, 25 HC Wainwright & Co.
BuyJan 14, 25 HC Wainwright & Co.
BuyJan 6, 25 HC Wainwright & Co.
BuyDec 23, 24 HC Wainwright & Co.
BuyNov 18, 24 BTIG
BuyNov 8, 24 HC Wainwright & Co.
BuySep 12, 24 HC Wainwright & Co.
BuyAug 15, 24 HC Wainwright & Co.
BuyJun 14, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for VYNE Therapeutics?
- Does VYNE Therapeutics pay dividends?
- What sector is VYNE Therapeutics in?
- What industry is VYNE Therapeutics in?
- What country is VYNE Therapeutics based in?
- When did VYNE Therapeutics go public?
- Is VYNE Therapeutics in the S&P 500?
- Is VYNE Therapeutics in the NASDAQ 100?
- Is VYNE Therapeutics in the Dow Jones?
- When was VYNE Therapeutics's last earnings report?
- When does VYNE Therapeutics report earnings?
- Should I buy VYNE Therapeutics stock now?
What is the ticker symbol for VYNE Therapeutics?
The ticker symbol for VYNE Therapeutics is NASDAQ:VYNE
Does VYNE Therapeutics pay dividends?
No, VYNE Therapeutics does not pay dividends
What sector is VYNE Therapeutics in?
VYNE Therapeutics is in the Healthcare sector
What industry is VYNE Therapeutics in?
VYNE Therapeutics is in the Biotechnology industry
What country is VYNE Therapeutics based in?
VYNE Therapeutics is headquartered in United States
When did VYNE Therapeutics go public?
VYNE Therapeutics's initial public offering (IPO) was on January 25, 2018
Is VYNE Therapeutics in the S&P 500?
No, VYNE Therapeutics is not included in the S&P 500 index
Is VYNE Therapeutics in the NASDAQ 100?
No, VYNE Therapeutics is not included in the NASDAQ 100 index
Is VYNE Therapeutics in the Dow Jones?
No, VYNE Therapeutics is not included in the Dow Jones index
When was VYNE Therapeutics's last earnings report?
VYNE Therapeutics's most recent earnings report was on Mar 6, 2025
When does VYNE Therapeutics report earnings?
The next expected earnings date for VYNE Therapeutics is May 9, 2025
Should I buy VYNE Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions